These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


565 related items for PubMed ID: 20620519

  • 1. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [Abstract] [Full Text] [Related]

  • 2. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 3. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 4. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
    Liver Transpl; 2007 Jun 15; 13(6):904-12. PubMed ID: 17539010
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients.
    Wiederkehr JC, Coelho IM, Avilla SG, e Silva EM, Schuller S, Ouno DD, Wiederkehr BA, Polimeni M.
    Transplant Proc; 2010 Mar 15; 42(2):521-2. PubMed ID: 20304183
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 7. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 8. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK.
    Liver Transpl Surg; 1999 May 15; 5(3):184-91. PubMed ID: 10226108
    [Abstract] [Full Text] [Related]

  • 9. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
    Deng Z, Jiang L, Zhou T, Shen C, Chen Q, Xia Q.
    Zhonghua Er Ke Za Zhi; 2014 Aug 15; 52(8):579-82. PubMed ID: 25224233
    [Abstract] [Full Text] [Related]

  • 10. Posttransplant lymphoproliferative disorder in pediatric liver transplantation.
    Uribe M, Hunter B, Alba A, Calabrán L, Flores L, Soto P, Herzog C.
    Transplant Proc; 2009 Aug 15; 41(6):2679-81. PubMed ID: 19716000
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar 15; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 12. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
    Heo JS, Park JW, Lee KW, Lee SK, Joh JW, Kim SJ, Lee HH, Lee DS, Choi SH, Seo JM, Choe YH.
    Transplant Proc; 2004 Oct 15; 36(8):2307-8. PubMed ID: 15561231
    [Abstract] [Full Text] [Related]

  • 13. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
    Manlhiot C, Pollock-Barziv SM, Holmes C, Weitzman S, Allen U, Clarizia NA, Ngan BY, McCrindle BW, Dipchand AI.
    J Heart Lung Transplant; 2010 Jun 15; 29(6):648-57. PubMed ID: 20304682
    [Abstract] [Full Text] [Related]

  • 14. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL, Strocker AM.
    Laryngoscope; 2001 Jun 15; 111(6):997-1001. PubMed ID: 11404611
    [Abstract] [Full Text] [Related]

  • 15. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 15; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 16. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A.
    Transplant Proc; 2006 Mar 15; 38(2):641-5. PubMed ID: 16549195
    [Abstract] [Full Text] [Related]

  • 17. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Mar 15; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 18. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 15; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 19. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 20. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.